RINVOQ for ulcerative colitis In clinical studies, RINVOQ helped people living with UC experience remission at 8 weeks and 1 year.

USE RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, …

RINVOQ for UC RINVOQ: A once-daily pill for moderate to severe ulcerative colitis When you and your gastroenterologist are considering ulcerative colitis medications, it's important to discuss …

Learn about RINVOQ® (upadacitinib) for moderate to severe ulcerative colitis (UC) and find frequently asked questions. See Full Prescribing & Safety Info, and Boxed Warning.

Learn about treatment options for moderate to severe ulcerative colitis (UC), including RINVOQ® (upadacitinib). See Full Prescribing & Safety Info, and Boxed Warning.

Prioritize setting proactive ulcerative colitis (UC) treatment goals with your gastroenterologist. See Full Prescribing & Safety Info, and Boxed Warning.

See results from clinical studies of people taking RINVOQ® (upadacitinib) for ulcerative colitis (UC). See Full Prescribing & Safety Info, and Boxed Warning.

Learn about how RINVOQ® (upadacitinib) works to treat moderate to severe ulcerative colitis (UC). See Full Prescribing & Safety Info, and Boxed Warning.

Learn about ulcerative colitis (UC) treatment options and how RINVOQ® (upadacitinib) may be an option. See Full Prescribing & Safety Info, and Boxed Warning.

RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and …